Cases & Deals

Wellington Partners invests in Genticel

Client(s) Wellington Partners Advisory AG

Jones Day advised Wellington Partners Advisory AG in connection with its purchase of €4 million of Series C Preferred Stock in an €18.2 million private placement by Genticel, a developer of therapeutic vaccines against HPV infection with high-risk types. The remaining €14.2 million was provided by existing shareholders EdRIP, IDInvest, InnoBio, IRDI, and Amundi.